Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis

BACKGROUND: Multiple myeloma (MM) is associated with high risk of venous thromboembolism (VTE). Thromboprophylaxis is thoroughly studied in MM. Contrarily, studies assessing the risk of bleeding in people with MM on anticoagulation are lacking. OBJECTIVES: To determine the rate of serious bleeding i...

Descripción completa

Detalles Bibliográficos
Autores principales: Adrianzen-Herrera, Diego, Lutsey, Pamela L., Giorgio, Katherine, Walker, Robert F., Zakai, Neil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982328/
https://www.ncbi.nlm.nih.gov/pubmed/36873562
http://dx.doi.org/10.1016/j.rpth.2022.100024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982328/
https://www.ncbi.nlm.nih.gov/pubmed/36873562
http://dx.doi.org/10.1016/j.rpth.2022.100024

Ejemplares similares